Home > Share Market > Stocks > Glaxosmithkline pharmaceuticals > Financial Statements > GLAXO Balance Sheet

Glaxosmithkline Pharmaceuticals Ltd Financial Statements

Glaxosmithkline Pharmaceuticals Ltd Balance Sheet

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar ( In .Cr) Mar-2021 Mar-2020 Mar-2019 Mar-2018
Equity capital 169 169 169 84.70
Preference capital -- -- -- --
Reserves 1,330 1,651 1,970 1,973
Net worth 1,499 1,821 2,140 2,057
Minority interest
Debt 0.02 0.18 0.58 0.99
Deferred tax liabilities (net) 15.60 17.20 24.10 16.20
Total liabilities 1,515 1,838 2,165 2,075
Fixed assets 399 878 1,434 1,247
Intangible assets
Investments -- -- 0.06 0.06
Deferred tax asset (net) 119 128 86.30 120
Net working capital (161) (251) (527) (589)
Inventories 547 483 486 500
Inventory Days 62.40 54.70 -- --
Sundry debtors 216 99.80 120 147
Debtor days 24.60 11.30 -- --
Other current assets 691 479 636 653
Sundry creditors (467) (381) (483) (646)
Creditor days 53.20 43.10 -- --
Other current liabilities (1,148) (931) (1,288) (1,243)
Cash 1,158 1,083 1,171 1,296
Total assets 1,515 1,838 2,165 2,075

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000